Brain scans reveal how gut talks to brain in obesity
NCT ID NCT05437653
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study used MRI to examine how the brain and gut communicate after eating different types of drinks in people with obesity and healthy weight. Researchers gave participants a high-fat drink or a carbohydrate drink and scanned their brains and stomachs. The goal was to develop better imaging methods and understand why some people may be heavier than others.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Nutritional drinks (high-fat emulsion and carbohydrate drink)
- What this could lead to
- If successful, this could help explain how the brain and gut interact to control appetite, potentially pointing toward new approaches for managing obesity.
- What could go wrong
- This is a small, early-stage imaging study with only 24 participants. It is designed to develop methods, not test a treatment, so direct benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 18-45, male and female (females will have the study days arranged during the early phase of the menstrual cycle). * Body mass index (BMI): normal weight participants ≥ 19 and ≤ 25 Kg/m2, and obese participants \> 30 Kg/m2 * Able to give voluntary written informed consent to participate in the study * Able to understand the requirements of the study * Apparently healthy: no medical conditions which might affect study measurements (judged by health questionnaire, and blood screening) Exclusion Criteria: * Any reported history of neurological or gastrointestinal disorders * Any reported history of surgery that could affect gastrointestinal function (e.g. colectomy, small bowel resection) * Abnormal screening procedures including depression and eat restriction * Laboratory results that are clinically significant, including diabetes, dyslipidemia, pancreatitis, or untreated hypertension. * Contraindications for MRI scanning i.e. metallic implants, pacemakers, history of metallic foreign body in eye(s) and penetrating eye injury, assessed by standard MRI safety questionnaire. * Under medication (expect aspirin/paracetamol), antibiotic or prescribed probiotic treatment in the past 12 weeks. * Following a medically- or self-prescribed diet during the two weeks prior to the pre-study examination and until the end of the study. * Reported weight loss or gain ≥ 10 % of bodyweight during the six months period before the pre-study examination * Pregnancy or breastfeeding declared by candidate * Smoking * Left-handed assessed by handedness questionnaire. This is to control for brain's lateralisation effects (activation in one side of the brain) that may show variations between left and right handed participants. * Participation in another clinical or research study within the previous 3 months of the study * Cannot lie flat or exceeding the scanner bed weight limit of 250 kg. * Poor understanding of the spoken and/or written English language
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Nottingham
Nottingham, NG7 2RD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?